Today: 20 May 2026
Browse Category

TSX:8630 17 August 2025

AI Stock Frenzy: Hedge Funds Pile In, Tesla’s Dojo U-Turn & Palantir’s Reality Check

AI Stock Frenzy: Hedge Funds Pile In, Tesla’s Dojo U-Turn & Palantir’s Reality Check

Bridgewater Associates more than doubled its Nvidia stake to 7.23 million shares, worth $1.14 billion, and sharply increased holdings in Alphabet and Microsoft in Q2. Tiger Global Management added 4 million Amazon shares, ending June with 10 million. U.S. authorities approved Nvidia and AMD to resume AI chip sales to China, with revenue-sharing requirements. Tesla halted its Dojo AI supercomputer project and shifted to in-house AI chips.
17 August 2025
··········

Stock Market Today

  • 15 S&P 500 Stocks Show Contrarian Potential Amid Market Rally
    May 20, 2026, 10:18 AM EDT. Fifteen S&P 500 stocks have fallen this year despite rising consensus earnings per share (EPS) estimates. This divergence offers a contrarian investment angle amid the market's uneven rally, as investors weigh improving company fundamentals against share price weakness. Analysts see value opportunities in companies where EPS forecasts are strong but stock prices have yet to reflect this optimism.

Latest articles

Nokia’s U.S. Broadband Win Lands as Its AI Rally Faces a Supply Test

Nokia’s U.S. Broadband Win Lands as Its AI Rally Faces a Supply Test

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
Go toTop